...Good morning. I'm Nello Mainolfi, President and CEO of Kymera Therapeutics, and I will act as Chairperson of this meeting. I'm pleased to welcome you to the Kymera Therapeutics 2024 Annual Meeting of Shareholders. Before I call the meeting to order, I would like to introduce you to the members of our Board and our executive team who are with us here today. Members of the Board with us here today are Mr. Jeffrey Albers, Dr. Felix Baker, Dr. Bruce Booth, Dr. Pamela Esposito, Dr. Joanna Horobin, Dr. Gorjan Hrustanovic, Dr. John Maraganore, Ms. Leigh Morgan, Ms. Elena Ridloff, Dr. Victor Sandor. The other executive officers of the corporation with us today are Dr. Jeremy Chadwick, our Chief Operating Officer; Mr. Ellen Chiniara, our Chief Legal Officer and Corporate Secretary; Dr. Jared Gollob as our Chief Medical Officer; Mr. Bruce Jacob, our Chief Financial Officer. I would like also to introduce you to Brendan McCorry of Ernst & Young, the corporation's independent registered public accounting...